DEPLOYDatabase

Robot model

ReWalk 7

Powered lower-limb personal exoskeleton; latest ReWalk generation, FDA cleared March 2025.

Track ReWalk 7
Manufacturer
Lifeward
Form factor
exoskeleton
Maturity
commercial
Lifecycle
active
Deployments
2
Website
ir.golifeward.com ↗

Overview

Powered lower-limb personal exoskeleton; latest ReWalk generation, FDA cleared March 2025. Motor-driven powered gait for spinal-cord-injury users.

Verified vs. claimed

Maturity stage
commercial(Commercially deployed with revenue-generating operations.)
Verified deployments
2 deployments on file
Sources on file
2 sources, view all

Key facts

Type

Exoskeleton for rehabilitation

Specs

Use

medical (personal, SCI)

Control

weight-shift triggered powered gait

Powered

yes (motor-driven)

Regulatory

FDA cleared 2025-03

Body region

lower-limb

Availability

commercial (2025 launch)

Data & sources

Press releases

1

Web sources

1

2 sources backing this record.View all →

Pricing

No verified price is on record for ReWalk 7. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

How DEPLOY tracks pricing

Deployments (2)

  • ReWalk 7 at United Statesoperational

    ReWalk 7 Personal Exoskeleton launched nationally in the US in April 2025.

  • ReWalk 7 at United Statesoperational

    ReWalk 7 (FDA cleared March 2025) is the latest generation personal exoskeleton for spinal-cord-injury users.

ReWalk 7 on the deployment map

Where ReWalk 7 is verified operating. Explore the deployment map by place and type.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Deployment-verified media (1)

PRIMARY SOURCE
Courtesy of Lifeward

Lifeward's footage of a user navigating stairs and curbs in the current-generation ReWalk personal exoskeleton (ReWalk 7). Stepping is triggered by tilt sensors and the user's forward body-weight shift, with crutches for balance: worn and user-controlled, not autonomous.

From deployment: United States

Regulatory filings (2)

Safety record

No incidents on record for ReWalk 7.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (2)

  1. https://ir.golifeward.com/news-releases/news-release-details/fda-issues-clearance-rewalk-7-exoskeleton
  2. https://golifeward.com/

Common questions

What is ReWalk 7?
Powered lower-limb personal exoskeleton; latest ReWalk generation, FDA cleared March 2025. Motor-driven powered gait for spinal-cord-injury users.
How much does ReWalk 7 cost?
ReWalk 7's price is not publicly disclosed. DEPLOY has no verified price on record for ReWalk 7 from Lifeward. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is ReWalk 7 actually deployed in the real world?
Yes. ReWalk 7 is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes ReWalk 7?
ReWalk 7 is made by Lifeward, based in Marlborough, MA, USA / Yokneam Ilit, Israel, founded in 2001.
Where is ReWalk 7 deployed?
2 verified deployments of ReWalk 7 are on the DEPLOY registry, including at United States.
Methodology: Verified · 2 sources (1 primary) · last reviewed 2026-07-08

Verification posture

Verified

High confidence

Review state

Stable

Last reviewed 2026-07-08

Maturity + lifecycle

Maturity stage: commercial

Lifecycle: active

Architectural position

Cohort: exoskeleton

Sources by quality tier

1
primary-company-ir
Company IR disclosure
1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for ReWalk 7.